000146907 001__ 146907
000146907 005__ 20231027183232.0
000146907 022__ $$a2095-3941
000146907 022__ $$a2095-3941$$l2095-3941
000146907 0247_ $$2ZDBID$$aPERI:(DE-600)2676322-9
000146907 0247_ $$2ZDBPPN$$aZDPPN:1024875466
000146907 0247_ $$2EZBID$$aPERI:(DE-606)186143
000146907 0247_ $$2OCLC$$aOCLC:812213198
000146907 0247_ $$2JCR$$aJCR:CANCER BIOL MED
000146907 0247_ $$2ISI$$aWOS:CANCER BIOLOGY & MEDICINE
000146907 0247_ $$2SCOPUS$$aSCOPUS:21100237607
000146907 0247_ $$2Medline$$amedline:101588850
000146907 035__ $$aPERI:(DE-600)2676322-9
000146907 040__ $$a4002$$bger$$cDE-101$$dJOIN²$$eJOIN² journal identification
000146907 041__ $$aeng
000146907 044__ $$cXB-CN
000146907 082__ $$222sdnb$$a610$$qDE-600
000146907 08274 $$222sdnb$$a610$$qDE-600
000146907 084__ $$2fid$$aASIEN$$qDE-1a
000146907 2100_ $$2DE-600$$aCancer Biol Med
000146907 2100_ $$2dnlm$$aCancer Biol Med
000146907 2100_ $$2iso$$aCancer Biol Med
000146907 24220 $$2DE-600$$aCancer biology & medicine$$cZhong guo kang ai xie hui$$yen
000146907 24220 $$2DE-600$$6246-01/Hans$$a癌症生物学与医学$$iParalleltitel$$yHans
000146907 24220 $$2DE-600$$aCancer biology & medicine$$cZhong guo kang ai xie hui
000146907 245__ $$2DE-600$$aCancer biology & medicine$$cZhong guo kang ai xie hui$$honline, print
000146907 2463_ $$2DE-600$$aCancer biology & medicine
000146907 2463_ $$aCancer biology & medicine
000146907 2463_ $$aClinical oncology and cancer research
000146907 260__ $$aTianjin$$bMedical Univ. Cancer Inst. & Hospital$$c2012-
000146907 2607_ $$2DOAJ$$aChina$$bChina Anti-Cancer Association$$d2019-02-25T09:25:10Z
000146907 26431 $$aTianjin$$bMedical Univ. Cancer Inst. & Hospital$$c2012-
000146907 3620_ $$2DE-600$$a9.2012 -
000146907 36301 $$2DE-600$$81.1\x$$a9$$i2012
000146907 365__ $$2DOAJ$$aAPC$$b1500$$cUSD$$d2019-02-25T09:25:10Z
000146907 380__ $$2marcgt$$ajournal
000146907 500__ $$aAutomatically generated record. (Updated: 2023-10-26)
000146907 540__ $$5PubMed Central$$aImmediate free access, All OpenAccess, Full coverage$$d2023-10-26
000146907 650_7 $$0ASJC:1306$$2ASJC$$aCancer Research
000146907 650_7 $$0ASJC:2730$$2ASJC$$aOncology
000146907 65310 $$2EZB-Subject$$aBiologie, Biotechnologie
000146907 65310 $$2EZB-Subject$$aMedizin
000146907 65310 $$2EZB-Keyword$$aBiomedizin,Onkologie
000146907 65310 $$2DOAJ$$acancer genetics$$d2019-02-25T09:25:10Z
000146907 65310 $$2DOAJ$$aoncology clinical trials$$d2019-02-25T09:25:10Z
000146907 65310 $$2DOAJ$$atargeted therapy and immunology$$d2019-02-25T09:25:10Z
000146907 65310 $$2DOAJ$$acancer and stem cell biology$$d2019-02-25T09:25:10Z
000146907 65310 $$2DOAJ$$acancer prevention and epidemiology$$d2019-02-25T09:25:10Z
000146907 65310 $$2DOAJ$$acancer biomarkers$$d2019-02-25T09:25:10Z
000146907 65310 $$2DOAJ$$aMedicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens$$d2019-02-25T09:25:10Z
000146907 77608 $$2DE-600$$iErscheint auch als$$nDruck-Ausgabe$$tCancer biology & medicine$$x2095-3941
000146907 78000 $$2DE-600$$dBeijing : Springer, 2009-2011$$hOnline-Ressource$$iVorg.:$$tClinical oncology and cancer research$$w(DE-600)2594620-1$$x1868-324X
000146907 8564_ $$d0$$uhttp://erf.sbb.spk-berlin.de/han/caj/oversea.cnki.net/knavi/JournalDetail?pcode=CJFD&pykm=CJCO$$yVerlag; CrossAsia Link = Deutschlandweit zugänglich
000146907 8564_ $$d0$$uhttp://ezb.uni-regensburg.de/2676322$$yEZB
000146907 8564_ $$d0$$uhttp://www.cancerbiomed.org/index.php/cocr/about/editorialPolicies#focusAndScope$$yScope
000146907 8564_ $$d0$$uhttp://www.cancerbiomed.org/index.php/cocr/about/editorialPolicies#peerReviewProcess$$yReview process
000146907 8564_ $$d0$$uhttp://www.cancerbiomed.org/index.php/cocr/about/editorialTeam$$yEditorial board
000146907 8564_ $$d0$$uhttp://www.cancerbiomed.org/index.php/cocr/pages/view/instructions_authors$$yInstructions for Authors
000146907 8564_ $$d0$$uhttp://www.cancerbiomed.org/index.php/cocr/pages/view/instructions_authors#charges_$$yAPC information
000146907 8564_ $$d0$$uhttps://oversea.cnki.net/knavi/JournalDetail?pcode=CJFD&pykm=CJCO$$yVerlag = Deutschlandweit zugänglich
000146907 8564_ $$d0$$uhttps://www.cancerbiomed.org/content/by/year$$yVerlag = kostenfrei
000146907 8564_ $$d0$$uhttps://www.ncbi.nlm.nih.gov/pmc/journals/2000$$yVerlag = kostenfrei
000146907 880__ $$2DE-600$$6246-01/Hans$$a癌症生物学与医学$$iParalleltitel
000146907 8801_ $$2DE-600$$aCancer biology & medicine$$cZhong guo kang ai xie hui
000146907 909CO $$ooai:juser.fz-juelich.de:132531$$pauthority$$pauthority:PERI
000146907 909CO $$ooai:juser.fz-juelich.de:132531
000146907 915__ $$0StatID:(DE-HGF)0420$$2StatID$$aNationallizenz$$d2023-10-26$$wger
000146907 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bCANCER BIOL MED : 2022$$d2023-10-26
000146907 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2023-10-26
000146907 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2023-10-26
000146907 915__ $$0StatID:(DE-HGF)0320$$2StatID$$aDBCoverage$$bPubMed Central$$d2023-10-26
000146907 915__ $$0StatID:(DE-HGF)0501$$2StatID$$aDBCoverage$$bDOAJ Seal$$d2019-02-25T09:25:10Z
000146907 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ$$d2019-02-25T09:25:10Z
000146907 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bDOAJ : Anonymous peer review$$d2019-02-25T09:25:10Z
000146907 915__ $$0LIC:(DE-HGF)CCBYNCNV$$2V:(DE-HGF)$$aCreative Commons Attribution-NonCommercial CC BY-NC (No Version)$$bDOAJ$$d2019-02-25T09:25:10Z
000146907 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2023-10-26
000146907 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2023-10-26
000146907 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2023-10-26
000146907 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2023-10-26
000146907 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2023-10-26
000146907 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2023-10-26
000146907 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2023-10-26
000146907 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2023-10-26
000146907 915__ $$0StatID:(DE-HGF)9905$$2StatID$$aIF >= 5$$bCANCER BIOL MED : 2022$$d2023-10-26
000146907 915__ $$0StatID:(DE-HGF)0561$$2StatID$$aArticle Processing Charges$$d2023-10-26
000146907 915__ $$0StatID:(DE-HGF)0700$$2StatID$$aFees$$d2023-10-26
000146907 936__ $$aVorgänger:  Clinical oncology and cancer research
000146907 980__ $$aPERI
000146907 980__ $$aAUTHORITY